Completed
The Roundtable on Genomics and Precision Health and the Forum on Drug Discovery, Development, and Translation hosted a workshop on March 22, 2016 that assessed the current landscape of genomic-enabled drug discovery and development activities in industry, academia, and government, examined enabling partnerships and business models, and considered gaps and best practices in how data from populations could be collected with the goal of improving the drug discovery process.
Featured publication
Workshop
·2016
The process of discovering and developing a new drug or therapy is extremely costly and time consuming, and recently, it has been estimated that the creation of a new medicine costs on average more than $2 billion and takes 10 years to reach patients. The challenges associated with bringing new medi...
View details
Description
An ad hoc committee will plan and conduct a one day public workshop to examine and discuss how large-scale genetic data could be used to improve the likelihood of bringing effective and targeted therapies to patients. The goal of the workshop will be to address how progress could be made in discovering and validating promising targets and medicines for those targets by using the data collected from large-scale genetic studies. Discussions will be held with a broad array of stakeholders which may include representatives from pharmaceutical and biotech companies, IT and data science companies, research institutes, investors, providers, patients, payers, and regulators. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. A summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures.
Collaborators
Committee
Nadeem Sarwar
Chair
Rebecca Blanchard
Member
John Carulli
Member
Geoffrey Ginsburg
Member
David B. Goldstein
Member
William Hoos
Member
Gabriela Lavezzari
Member
Laura K. Nisenbaum
Member
Dina Paltoo
Member
Nalini Raghavachari
Member
Sponsors
Department of Health and Human Services
Other, Federal
Private: For Profit
Private: Non Profit
Staff
Sarah Beachy
Lead
Carolyn Shore
Lead
Meredith Hackmann
Amanda Wagner Gee
Olivia Yost
Siobhan Addie
Major units and sub-units
Health and Medicine Division
Lead
Institute of Medicine
Lead
Board on Health Sciences Policy
Lead